The peptide primarily activates melanocortin receptor subtypes MC1R, MC3R, MC4R, and MC5R, with particular affinity for MC3R and MC4R at therapeutic doses
Sevmias price has not been published yet
The active pharmaceutical ingredient, tirzepatide , shares a similar mechanism of action with semaglutide , but boasts a superior design, with its activity reported to be three times that of semaglutide
However, it might be covered by some plans and with prior authorization
A staged approach, particularly for those with significant weight fluctuations, prioritizes safety
In addition to appetite suppression, semaglutide can address many other health-related issues